A biological model for the assay of typhoid vaccines
Diena, B.B.; Wallace, R.; Sato, H.; Ueda, K.; Greenberg, L.
Revue Canadienne de Biologie 29(4): 347-351
1970
ISSN/ISBN: 0035-0915 PMID: 5513577 Document Number: 24516
Document emailed within 1 workday
Related Documents
Sethi, S.; Sharma, S.; Das, A.; Ray, P.; Bhalla, A.; Sharma, M. 2006: Evaluation of typhoid assay for rapid diagnosis of typhoid fever Journal of the Association of Physicians of India 54: 159Paniagua, J.; García, J.A.; López, C.R.; González, C.R.; Isibasi, A.; Kumate, J. 1992: Conjugate vaccines against bacterial infections: typhoid fever Salud Publica de Mexico 34(3): 268-273
Steele, A.D.; Carey, M.E.; Kumar, S.; MacLennan, C.A.; Ma, L.-F.; Diaz, Z.; Zaidi, A.K.M. 2020: Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next? Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(Suppl 2): S185-S190
Miller, S.I.; Mekalanos, J.J. 1989: Strategies for the development of vaccines for typhoid fever, shigellosis, and cholera Annals of the new York Academy of Sciences 569: 145-154
Acosta, C.J.; Galindo, C.M.; Ochiai, R.Leon.; Danovaro-Holliday, M.Carolina.; Page, A-Laure.; Thiem, V.Dinh.; Park, J.Kyoung.; Park, E.; Koo, H.; Wang, X-Yi.; Abu-Elyazeed, R.; Ali, M.; Albert, M.John.; Ivanoff, B.; Pang, T.; Xu, Z-Yi.; Clemens, J.D. 2004: The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia Journal of Health Population and Nutrition 22(3): 240-245
Shteĭnberg, O.I. 1971: Vaccinal reactions in children to administration of typhoid vaccines (clinical-laboratory characteristics) Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 48(7): 34-37
Terrier, N.; Bonardet, A.; Descomps, B.; J.Cristol, P.; A.M. Dupuy 2004: Determination of ß 2 -Microglobulin in Biological Samples Using an Immunoenzymometric Assay (Chemiluminescence Detection) or an Immunoturbidimetric Assay: Comparison with a Radioimmunoassay Clinical Laboratory 50(11-12): 675-683
Meniavtseva, T.A.; Vasil'ev, N.V. 1973: Comparative characteristics of the reaction of bone marrow hematopoiesis to the administration of typhoid and tick-borne encephalitis vaccines Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 50(11): 71-75
Kovalevskaia, I.L.; Shchelova, E.S.; Ermolenko, Z.N.; Braĭnina, R.A.; Shandalov, B.I. 1975: Comparative evaluation of the immunological activity of new typhoid vaccines with established prophylactic effectiveness (data from a controlled experiment) Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 9: 63-68
Scratcherd, T.; Case, R.M.; Smith, P.A. 1975: A sensitive method for the biological assay of secretin and substances with "secretin-like" activity in tissues and biological fluids Scandinavian Journal of Gastroenterology 10(8): 821-828
Lavergne, G.M.; James, H.F.; Martineau, C.; Diena, B.B.; Lior, H. 1977: The guinea pig as a model for the asymptomatic human typhoid carrier Laboratory Animal Science 27(5 Part 2): 806-816
Ledwith, B.J.; Manam, S.; Troilo, P.J.; Barnum, A.B.; Pauley, C.J.; Griffiths, T.G.; Harper, L.B.; Schock, H.B.; Zhang, H.; Faris, J.E.; Way, P.A.; Beare, C.M.; Bagdon, W.J.; Nichols, W.W. 2000: Plasmid DNA vaccines: assay for integration into host genomic DNA Developments in Biologicals 104: 33-43
Carozzi, F.M. 2007: Biological basis for HPV vaccines Epidemiologia e Prevenzione 31(2-3): 92-99
Zhao, R.; Fang, J.-s.; Liu, A.-l.; Du, G.-h. 2015: Development of HTS model on SERT inhibitors combined biological screening model with HTVS Yao Xue Xue Bao 50(9): 1116-1121
1999: Drugs and vaccines against biological weapons Medical Letter on Drugs and Therapeutics 41(1046): 15-16
Rivero Puente, A.; Burusco, M.J.; Idoate, I.; Fernández-Calvo, J.L.; García Merlo, S. 1977: Typhoid fever: clinico-biological evaluation and therapeutic response in 90 patients admitted to an internal medicine service Revista Clinica Espanola 147(2): 175-178
Pass, H.A.; Schwarz, S.L.; Wunderlich, J.R.; Rosenberg, S.A. 1998: Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay Cancer Journal From Scientific American 4(5): 316-323
Maas, R.; Komen, M.; Oei, H.; Claassen, I. 2002: Validation of a candidate in vitro potency assay for inactivated Newcastle disease vaccines Developments in Biologicals 111: 163-169
M'Henni, A. 1997: Laboratory for the control of serum vaccines and other biological products Archives de l'Institut Pasteur de Tunis 74(1-2): 129-133
Mwau, M.; McMichael, A.J.; Hanke, T.ás. 2002: Design and validation of an enzyme-linked immunospot assay for use in clinical trials of candidate HIV vaccines Aids Research and Human Retroviruses 18(9): 611-618